Xconomy San Diego

Illumina Countersues Life Technologies

Bruce V. Bigelow10/14/09

San Diego-based Illumina (NASDAQ: ILMN) and its Solexa subsidiary are countersuing Carlbad, CA-based Life Technologies (NASDAQ: LIFE) and Applied Biosystems in a patent dispute over gene sequencing technologies. In a statement today, Illumina and Solexa denied allegations that Life and Applied Biosystems raise in their Sept. 21 lawsuit, assert that Applied Biosystems’ patents are invalid, and allege that Life is infringing on four Solexa patents. A Life spokesman says, “We believe these claims are without merit and we will vigorously defend our intellectual property.”

Bruce V. Bigelow is the editor of Xconomy San Diego. You can e-mail him at bbigelow@xconomy.com or call (619) 669-8788

Add Your Thoughts

You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted.
By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.